OUR TEAM

FREDERICK JIANG
Partner

Frederick Jiang founded Falcon Creek in 2019, focusing on biotechnology venture investment. He has more than 30 years of global investment experience and earned an MBA from NYU Stern. He began his career in ABN AMRO Asia investment banking and later served as Senior Portfolio Manager at Waddell & Reed Financial and Ivy Funds, managing international portfolios for endowments, insurers, and high-net-worth clients. A two-time Lipper Fund Awards winner, he co-founded Coalescence Partners Investment Management in 2016 and managed hedge and private-equity funds.

CHRISTOPHER W. KENNEDY
Board Advisor

Christopher W. Kennedy has two decades of executive leadership experience across the pharmaceutical, biotechnology, medical-device, pharmacy, and clinical-research sectors. His work includes launching early-stage cell- and gene-therapy companies. His commercial efforts helped achieve over $2.2 billion in combined M&A exits.

JEFF HARGROVES
Board Advisor

Jeff Hargroves has more than 35 years of healthcare experience. He is the founder and former President and CEO of ProPharma Group, with prior roles in operations, quality assurance, and engineering. He is an active investor and board member across private-company, industry, civic, and philanthropic organizations.

CRAIG MACY
General Counsel

Craig Macy is an attorney and business executive with 25 years of experience at venture-backed technology companies and law firms. He brings operational, legal, transactional, and intellectual-property experience in biotechnology and earned his JD from Harvard Law School.